NCT07198633 2026-06-02A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate CancerQilu Pharmaceutical Co., Ltd.Phase 1/2 Recruiting212 enrolled